ALX Oncology Holdings Inc. (ALXO) delivered a return of 314.93% over the past year. Since ALXO does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in ALX Oncology Holdings Inc. one year ago would be worth $41,493 today, representing a gain of $31,493.

ALX Oncology Holdings Inc. (ALXO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ALXO, the total return equals the price-only return.

Yes, ALX Oncology Holdings Inc. (ALXO) outperformed the S&P 500 by 283.61 percentage points over the past year. ALXO delivered a total return of 314.93%, compared to the S&P 500's 31.32%. This 283.61pp alpha means investors in ALXO earned more than a passive S&P 500 index fund.

ALX Oncology Holdings Inc. (ALXO) experienced a maximum drawdown of -50.46% over the past year, declining from its peak on 2025-10-03 to its trough on 2026-01-06. The stock recovered to its prior peak by 2026-02-09. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are ALX Oncology Holdings Inc. (ALXO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -93.0% (-23.4% CAGR) — $10,000 would have grown to $697. Over 20 years: -93.0% total return (-12.5% CAGR) — $10,000 → $697. Over 30 years: -93.0% total return (-8.5% CAGR) — $10,000 → $697. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

ALX Oncology Holdings Inc.'s best calendar year was 2020 with a total return of 187.3%. Its worst year was 2024 with a total return of -88.5%. This range shows the volatility investors should expect — the difference between the best and worst year is 275.9 percentage points.